Drug: FABRAZYME Injury: Nasopharyngitis Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127003241 | FABRAZYME | Nasopharyngitis | AVENTIS | 52.00 YR | M | 0 | 20160830 | US |
127004181 | FABRAZYME | Nasopharyngitis | AVENTIS | 45.00 YR | M | 94 KG | 20160830 | US |
127004381 | FABRAZYME | Nasopharyngitis | AVENTIS | 46.00 YR | M | 77 KG | 20160830 | US |
127004461 | FABRAZYME | Nasopharyngitis | AVENTIS | 63.00 YR | F | 89 KG | 20160830 | US |
127004631 | FABRAZYME | Nasopharyngitis | AVENTIS | 35.00 YR | M | 0 | 20160830 | US |
127004681 | FABRAZYME | Nasopharyngitis | AVENTIS | 43.00 YR | F | 136 KG | 20160830 | US |
127004941 | FABRAZYME | Nasopharyngitis | AVENTIS | 45.00 YR | M | 90 KG | 20160830 | US |
1119894111 | FABRAZYME | Nasopharyngitis | AVENTIS | 56.00 YR | M | 0 | 20160701 | AU |
Total Records: 8 Number of Pages: 1